Clinical Trial Update: A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update notes the completion of an EARLY_PHASE1 study evaluating vismodegib in men with metastatic castration-resistant prostate cancer with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Vismodegib (Vismodegib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2018-07-20